Effects of HA1 (a Probucol Analogue) and ApoC3 siRNA on Lipoprotein-Amyloid Metabolism, Neurovascular Integrity and Cognitive Function in db/db Mice
Arazu Sharif,John Mamo,Virginie Lam,Gerald F Watts,Giuseppe Luna,Michael Nesbit,Armin Mooranian,Hani Al-Salami,Ryu Takechi
DOI: https://doi.org/10.1101/2024.11.05.622070
2024-11-05
Abstract:Abstract
Background and aims
Chronically elevated levels of circulating lipoprotein-amyloid-beta (Abeta) are implicated in the disruption of the blood-brain barrier and the initiation of a neurodegenerative cascade leading to Alzheimers disease (AD). Type 2 diabetes is associated with BBB dysfunction, dyslipidaemia, and an increased risk of AD. However, alterations in triglyceride-rich lipoproteins (TRL)-Abeta homeostasis and its downstream effects on the BBB in a diabetes context remain explored. This study aimed to 1) investigate, in a preclinical model of diabetes, the hypothesis that diabetes-induced impairments in TRL-Abeta metabolism might compromise BBB integrity and exacerbate cognitive function and behavioural changes, and 2) assess the efficacy of interventions that improve TRL catabolism, including probucol, HA1, and ApoC3 siRNA, to prevent disease progression by lowering circulating TRL-Abeta levels.
Methods
Five-week-old db/db mice underwent a 9- or 23-weeks dietary interventions with probucol, a probucol prodrug HA1, or a standard diet with four-weekly injections of ApoC3 siRNA. Db/+ mice served as negative controls for each treatment duration. Blood levels of Abeta and ApoB were measured using ELISA. Immunofluorescence imaging was used to quantify enterocytic levels of Abeta and ApoB, and assess changes in neurovascular integrity (IgG, PDGFRbeta, ZO1, occludin), neuroinflammation (GFAP, Iba1), and cerebral oxidative stress (8OHdG).
Results
Our results indicate that diabetes increased the abundance of plasma amyloid, specifically Abeta42, which correlated with enterocytic abundance, suggesting exaggerated postprandial excretion. Disrupted plasma amyloid homeostasis was associated with BBB breakdown, including diminished barrier function, and the loss of pericytes and astrocytes. Provision of the probucol analogue, HA1, normalised plasma and enterocytic amyloidemia concomitant with the preservation of the neurovascular junction. Treatment with ApoC3 siRNA attenuated plasma Abeta42 and modestly reduced neurovascular inflammation.
Conclusion
The findings further support the hypothesis that aberrant peripheral metabolism of lipoprotein-Abeta is associated with microvascular corruption and the development of anxiety-like behaviour. HA1 is more effective than probucol or ApoC3 siRNA in positively modulating lipoprotein-amyloid homeostasis in db/db mice and maintaining central capillary integrity.
Neuroscience